The M-OVIN study: Does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial

BMC Women's Health

Volumn 13, Issue 1, 2013, Pages

  Nahuis, Marleen J ^a   Weiss, Nienke S ^a   van der Veen, Fulco ^a   Mol, Ben Willem J ^a   Hompes, Peter G ^a   Oosterhuis, Jur ^a   Lambalk, Nils B ^a   Smeenk, Jesper M J ^a   Koks, Carolien A M ^a   van Golde, Ron J T ^a   Laven, Joop S E ^a   Cohlen, Ben J ^a   Fleischer, Kathrin ^a   Goverde, Angelique J ^a   Gerards, Marie H ^a   Klijn, Nicole F ^a   Nekrui, Lizka C M ^a   van Rooij, Ilse A J ^a   Hoozemans, Diederik A ^a   Van Wely, Madelon ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; GONADOTROPIN DERIVATIVE;

ANOVULATION; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; INTRAUTERINE INSEMINATION; MENSTRUAL CYCLE; MULTICENTER STUDY; MULTIPLE PREGNANCY; OUTCOME ASSESSMENT; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; REIMBURSEMENT; SEXUAL INTERCOURSE; SPONTANEOUS ABORTION; TRANSVAGINAL ECHOGRAPHY; WORLD HEALTH ORGANIZATION;

ANOVULATION; CLOMIPHENE; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; INSEMINATION, ARTIFICIAL; NETHERLANDS; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; TIME-TO-PREGNANCY; TREATMENT OUTCOME;

EID: 84887600826     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-13-42     Document Type: Article

References (27)

1. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.
2. Kousta E, White DM, Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 1997, 3:359-365. 10.1093/humupd/3.4.359, 9459281.
3. Kafy S, Tulandi T. New advances in ovulation induction. Curr Opin Obstet Gynecol 2007, 19:248-252. 10.1097/GCO.0b013e3280c60c9a, 17495641.
4. Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E. Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev 2009, (Issue 4).
5. Cudmore DW, Tupper WRC. Induction of ovulation with clomiphene citrate. Fertil Steril 1966, 17:363-373.
6. Garcia CR, Freeman EW, Rickels K, et al. Behavioral and emotional factors and treatment responses in a study of anovulatory infertile women. Fert Steril 1985, 44:478-483.
7. Johnson JE, Cohen MR, Goldferb AF, et al. The efficacy of clomiphene citrate for induction of ovulation. Int J Fertil 1966, 11:265-270.
8. Moll E, Korevaar JC, Bossuyt PM, van der Veen F. Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?. Hum Reprod 2008, 23:1830-1834. 10.1093/humrep/den182, 2474667, 18487613.
9. Gysler M, March CM, Mishell DR, Bailey E. A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril 1982, 37:161-167.
10. Neveu N, Granger L, StMichel P, Lavoie HB. Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome. Fertil Steril 2007, 87:113-120. 10.1016/j.fertnstert.2006.05.069, 17081535.
11. Badawy A, Allam A, Abulatta M. Extending clomiphene treatment in clomiphene-resistant women with PCOS: a randomized controlled trial. Reprod BioMed Online 2008, 16:825-829. 10.1016/S1472-6483(10)60148-4, 18549692.
12. López E, Gunby J, Daya S, Parrilla JJ, Abad L, Balasch J. Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy. Reprod Biomed Online 2004, 9:382-390. 10.1016/S1472-6483(10)61273-4, 15511336.
13. Homburg Clomiphene citrate - end of an era? A mini review. Human reproduction 2005, 20:2043-2051. 10.1093/humrep/dei042, 15878925, Homburg.
14. van Wely M, Bayram N, van der Veen F, Bossuyt PM. An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome. Hum Reprod 2004, 19:1741-1745. 10.1093/humrep/deh319, 15166128.
15. Van Wely M, Bayram N, Van Der Veen F, Bossuyt PM. Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndrome. Hum Reprod 2005, 1827-1832.
16. Bayram N, van Wely M, Kaaijk EM, Bossuyt PM, van der Veen F. Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial. BMJ 2004, 328:192. 10.1136/bmj.328.7433.192, 318481, 14739186.
17. Bayram N, van Wely M, van der Veen F, Bossuyt PM, Nieuwkerk P. Treatment preferences and trade-offs for ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril 2005, 84:420-425. 10.1016/j.fertnstert.2005.02.026, 16084884.
18. Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ 2006, 4:1485.
19. Hammond MG, Halme JK, Talbert LM. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet Gynecol 1983, 62:196-202.
20. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994, 331:771-776. 10.1056/NEJM199409223311204, 8065405.
21. Randall JM, Templeton A. Transvaginal sonographic assessment of follicular and endometrial growth in spontaneous and clomiphene citrate cycles. Fertil Steril 1991, 56:208-212.
22. Dickey RP, Olar TT, Taylor SN, Curole DN, Matulich EM. Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: effect of clomiphene citrate alone and with human menopausal gonadotropin. Fertil Steril 1993, 59:756-760.
23. Kolibianakis EM, Zikopoulos KA, Fatemi HM, Osmanagaoglu K, Evenpoel J, Van Steirteghem A, et al. Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination. Reprod Biomed Online 2004, 8:115-118. 10.1016/S1472-6483(10)60505-6, 14759299.
24. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008, 89:505-522. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
25. Bayram N, van Wely M, van der Veen F. Recombinant versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev 2001
26. Guzick DS. Ovulation induction management of PCOS. Clin Obstet Gynecol 2007, 50:255-267. 10.1097/GRF.0b013e31802f361e, 17304040.
27. Nice guideline. See http://www.nice.org.uk/nicemedia/live/10936/29269/29269.pdf.